BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12756265)

  • 1. Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection.
    Reading PC; Moore JB; Smith GL
    J Exp Med; 2003 May; 197(10):1269-78. PubMed ID: 12756265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.
    Reading PC; Smith GL
    J Virol; 2003 Sep; 77(18):9960-8. PubMed ID: 12941906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.
    Symons JA; Adams E; Tscharke DC; Reading PC; Waldmann H; Smith GL
    J Gen Virol; 2002 Nov; 83(Pt 11):2833-2844. PubMed ID: 12388820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection.
    Reading PC; Symons JA; Smith GL
    J Immunol; 2003 Feb; 170(3):1435-42. PubMed ID: 12538705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3-beta-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants.
    Sroller V; Kutinová L; Nĕmecková S; Simonová V; Vonka V
    Arch Virol; 1998; 143(7):1311-20. PubMed ID: 9722876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection.
    Reading PC; Smith GL
    J Gen Virol; 2003 Aug; 84(Pt 8):1973-1983. PubMed ID: 12867627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection.
    Benfield CTO; Ren H; Lucas SJ; Bahsoun B; Smith GL
    J Gen Virol; 2013 Jul; 94(Pt 7):1647-1657. PubMed ID: 23580427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice.
    Karupiah G; Woodhams CE; Blanden RV; Ramshaw IA
    J Immunol; 1991 Dec; 147(12):4327-32. PubMed ID: 1684375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses.
    Hayasaka D; Ennis FA; Terajima M
    Virol J; 2007 Feb; 4():22. PubMed ID: 17326843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant helminth infection downmodulates the Vaccinia virus-specific immune response and potentiates virus-associated pathology.
    Gazzinelli-Guimarães PH; de Freitas LF; Gazzinelli-Guimarães AC; Coelho F; Barbosa FS; Nogueira D; Amorim C; Dhom-Lemos LC; Oliveira LM; da Silveira AB; da Fonseca FG; Bueno LL; Fujiwara RT
    Int J Parasitol; 2017 Jan; 47(1):1-10. PubMed ID: 28003150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.
    Moore JB; Smith GL
    EMBO J; 1992 May; 11(5):1973-80. PubMed ID: 1582424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model.
    Pires de Miranda M; Reading PC; Tscharke DC; Murphy BJ; Smith GL
    J Gen Virol; 2003 Sep; 84(Pt 9):2459-2471. PubMed ID: 12917467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence.
    Symons JA; Tscharke DC; Price N; Smith GL
    J Gen Virol; 2002 Aug; 83(Pt 8):1953-1964. PubMed ID: 12124459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
    Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
    Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo.
    Hamilton NH; Mahalingam S; Banyer JL; Ramshaw IA; Thomson SA
    Scand J Immunol; 2004 Mar; 59(3):246-54. PubMed ID: 15030574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes.
    Tscharke DC; Reading PC; Smith GL
    J Gen Virol; 2002 Aug; 83(Pt 8):1977-1986. PubMed ID: 12124461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 17 modulates the immune response to vaccinia virus infection.
    Patera AC; Pesnicak L; Bertin J; Cohen JI
    Virology; 2002 Jul; 299(1):56-63. PubMed ID: 12167341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
    Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
    Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice.
    Tufariello JM; Cho S; Horwitz MS
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10987-91. PubMed ID: 7971996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.
    Fahy AS; Clark RH; Glyde EF; Smith GL
    J Gen Virol; 2008 Oct; 89(Pt 10):2377-2387. PubMed ID: 18796705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.